Streetbeat News

Products Services

MRNA

Moderna shares are trading lower after the company revised its 2024 expectations due to low EU sales, potential revenue deferrals for certain international sales into 2025, and an increasingly competitive environment for respiratory vaccines in the US.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:38 am

AULT

Ault Alliance plans to focus on its AI data center business, rebranding itself as Hyperscale Data, Inc. and changing its ticker symbol to GPUS.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:37 am

AGIO

Agios Pharmaceuticals announced that the Phase 3 ACTIVATE-KidsT study of Mitapivat in children with PK deficiency who are regularly transfused did not meet the prespecified statistical criterion for the primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:34 am

ITT

ITT Inc. has agreed to acquire kSARIA Parent, Inc., a producer of mission-critical connectivity solutions for the defense and aerospace markets, for approximately $475 million. The acquisition is expected to close in the third quarter of 2024, pending customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:32 am

SAVE

Spirit Airlines expects Q3 total revenue to be between $1.155B and $1.175B, below the estimated $1.331B. The company faces challenges from increased industry capacity and changes in ancillary pricing. Additionally, the elimination of change and cancellation fees is expected to impact revenue per passenger segment negatively through 2024. A recent operational disruption due to a CrowdStrike IT outage resulted in the cancellation of 470 flights, with an estimated $7.2 million negative impact on Q3 operating income.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:23 am

INFY

NOW

Infosys and ServiceNow have expanded their strategic collaboration to provide end-to-end managed services using AI capabilities. This partnership aims to accelerate ServiceNow implementation for enterprises, including First Abu Dhabi Bank, by 30-40%, leveraging Infosys' ESM Café and Cobalt services.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:20 am

TIL

Instil Bio and ImmuneOnco have entered into a license and collaboration agreement. Instil Bio will in-license ex-China development and commercial rights to ImmuneOnco's PD-L1xVEGF bispecific antibody, IMM2510, and next-generation anti-CTLA-4 antibody, IMM27M. ImmuneOnco will receive an upfront payment, potential near-term payments up to $50 million, and potential milestones exceeding $2 billion.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:12 am

GLSI

Greenwich LifeSciences (GLSI) has announced an update on the expansion of its clinical sites into Spain. So far, 30 out of 38 sites have conducted site initiation visits (SIVs). Partner GEICAM aims to complete the remaining SIVs in the coming months.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 10:06 am

ZK

ZEEKR Intelligent Technology Holding Limited (NYSE:ZK) reported a 30% YoY increase in vehicle deliveries for July 2024, with 15,655 units delivered. Year-to-date deliveries reached 103,525, up 89% from the previous year. The company also launched its luxury flagship MPV, the ZEEKR 009, and announced details about its mid-large SUV, the ZEEKR 7X.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:57 am

SAVE

Spirit Airlines is on track to achieve $100 million in annual run-rate cost savings, with $75 million expected by the end of 2024. The company is implementing various cost-saving initiatives, including suspending recruitment, offering voluntary unpaid leaves, and realigning its network by exiting 42 markets and adding 77 new ones. Additionally, Spirit has deferred aircraft orders with Airbus to 2030-2031.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 9:56 am